Search for: "Sandoz, Inc"
Results 421 - 440
of 679
Sorted by Relevance
|
Sort by Date
30 Aug 2011, 7:50 pm
Following the Fifth Circuit's decision in Sandoz v. [read post]
28 Oct 2010, 10:14 am
On June 28th, 2010, Sandoz Inc. replied to the Company’s correspondence. [read post]
9 Dec 2008, 3:24 pm
Sandoz, Inc. after the jump. [read post]
28 Jul 2010, 12:06 am
Sandoz, Inc. [read post]
2 Feb 2008, 2:00 am
Sandoz, Inc. [read post]
23 Sep 2009, 8:31 am
Sandoz, Inc. 2007-1400 (May 18, 2009 Fed. [read post]
10 Sep 2010, 1:21 am
Sandoz Inc. [read post]
16 Aug 2017, 8:21 am
” Sandoz, Inc. v. [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
17 Dec 2015, 11:40 am
Sandoz, Inc., 783 F.3d 853, 859 (Fed.Cir. 2015) (quoting Procter & Gamble Co. v. [read post]
12 Aug 2022, 6:48 pm
Sandoz, Inc., 574 U.S. 318, 332–33 (2015). [read post]
7 May 2009, 6:08 am
Sandoz Pharmaceuticals Corp., 188 F. [read post]
29 Jun 2018, 7:50 am
Amphastar Pharmaceuticals, Inc. [read post]
23 Dec 2013, 5:16 am
Sandoz Inc., 921 F. [read post]
28 Dec 2009, 7:57 am
The case is still proceeding against Dey, Inc., Mylan Pharmaceuticals, Inc., Sandoz, Inc. and their parent companies. [read post]
21 Jan 2010, 1:00 am
Sandoz Inc. [read post]
24 Mar 2014, 4:15 am
Sandoz Inc., 726 F.3d 1286 (Fed. [read post]
21 May 2009, 10:03 am
Sandoz, Inc., a decision that just screams for Congress to codify Rule 56 and settle once and for all the duty of candor that is owed to the Patent Office during the patent application process. [read post]
23 Dec 2009, 12:40 am
Sandoz Limited (EPLAW) Fuzeon (Enfuvirtide) - US: If there are no sources of proof in the E D of Texas, expect to transferred: In re Hoffman-La Roche Inc (Filewrapper) Gemzar (Gemcitabine) – US: Eli Lilly appeals from grant of partial summary judgment finding certain claims invalid for double patenting: Sun Pharma v Eli Lilly (PATracer) Gemzar (Gemcitabine) – US: Eli Lilly files patent infringement complaint against APP Pharmaceuticals following Para IV challenge… [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation (IP Law Observer) Lescol (Fluvastatin) - US: Mylan confirms first-to-file patent challenge to Lescol by Novartis (SmartBrief) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd & Anor… [read post]
